vs
Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $50.1M, roughly 1.1× ACACIA RESEARCH CORP). ACACIA RESEARCH CORP runs the higher net margin — 6.8% vs -83.0%, a 89.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 2.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 43.6%).
Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
ACTG vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.1M | $57.3M |
| Net Profit | $3.4M | $-47.5M |
| Gross Margin | 12.8% | 91.6% |
| Operating Margin | -26.1% | -82.2% |
| Net Margin | 6.8% | -83.0% |
| Revenue YoY | 2.6% | 36.9% |
| Net Profit YoY | 125.5% | -9.6% |
| EPS (diluted) | $0.03 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.1M | $57.3M | ||
| Q3 25 | $59.4M | $51.3M | ||
| Q2 25 | $51.2M | $48.5M | ||
| Q1 25 | $124.4M | $32.7M | ||
| Q4 24 | $48.8M | $41.8M | ||
| Q3 24 | $23.3M | $33.3M | ||
| Q2 24 | $25.8M | $29.1M | ||
| Q1 24 | $24.3M | $26.0M |
| Q4 25 | $3.4M | $-47.5M | ||
| Q3 25 | $-2.7M | $-52.9M | ||
| Q2 25 | $-3.3M | $-46.6M | ||
| Q1 25 | $24.3M | $-49.5M | ||
| Q4 24 | $-13.4M | $-43.3M | ||
| Q3 24 | $-14.0M | $-43.6M | ||
| Q2 24 | $-8.4M | $-32.3M | ||
| Q1 24 | $-186.0K | $-141.4M |
| Q4 25 | 12.8% | 91.6% | ||
| Q3 25 | 21.2% | 89.3% | ||
| Q2 25 | 12.8% | 88.6% | ||
| Q1 25 | 47.4% | 88.8% | ||
| Q4 24 | 17.6% | 90.9% | ||
| Q3 24 | 10.1% | 88.5% | ||
| Q2 24 | 26.2% | 89.9% | ||
| Q1 24 | 49.2% | 89.2% |
| Q4 25 | -26.1% | -82.2% | ||
| Q3 25 | -10.8% | -102.6% | ||
| Q2 25 | -24.2% | -93.4% | ||
| Q1 25 | 30.8% | -143.7% | ||
| Q4 24 | -32.4% | -98.6% | ||
| Q3 24 | -44.1% | -132.0% | ||
| Q2 24 | -18.4% | -139.2% | ||
| Q1 24 | -8.6% | -538.7% |
| Q4 25 | 6.8% | -83.0% | ||
| Q3 25 | -4.6% | -103.1% | ||
| Q2 25 | -6.4% | -96.1% | ||
| Q1 25 | 19.5% | -151.4% | ||
| Q4 24 | -27.5% | -103.6% | ||
| Q3 24 | -60.0% | -131.2% | ||
| Q2 24 | -32.7% | -110.9% | ||
| Q1 24 | -0.8% | -544.4% |
| Q4 25 | $0.03 | $-0.73 | ||
| Q3 25 | $-0.03 | $-0.82 | ||
| Q2 25 | $-0.03 | $-0.75 | ||
| Q1 25 | $0.25 | $-0.81 | ||
| Q4 24 | $-0.14 | $-0.71 | ||
| Q3 24 | $-0.14 | $-0.73 | ||
| Q2 24 | $-0.08 | $-0.55 | ||
| Q1 24 | $0.00 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $306.7M | $388.9M |
| Total DebtLower is stronger | $91.9M | — |
| Stockholders' EquityBook value | $543.5M | $139.1M |
| Total Assets | $771.0M | $480.2M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $306.7M | $388.9M | ||
| Q3 25 | $301.8M | $416.1M | ||
| Q2 25 | $316.7M | $291.0M | ||
| Q1 25 | $272.0M | $314.5M | ||
| Q4 24 | $273.9M | $320.6M | ||
| Q3 24 | $410.9M | $298.4M | ||
| Q2 24 | $441.9M | $319.1M | ||
| Q1 24 | $498.4M | $201.2M |
| Q4 25 | $91.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $543.5M | $139.1M | ||
| Q3 25 | $537.6M | $148.8M | ||
| Q2 25 | $538.6M | $-11.9M | ||
| Q1 25 | $540.2M | $18.9M | ||
| Q4 24 | $514.8M | $21.7M | ||
| Q3 24 | $540.2M | $11.2M | ||
| Q2 24 | $560.7M | $39.3M | ||
| Q1 24 | $568.3M | $61.6M |
| Q4 25 | $771.0M | $480.2M | ||
| Q3 25 | $768.9M | $506.9M | ||
| Q2 25 | $775.5M | $372.7M | ||
| Q1 25 | $801.6M | $386.7M | ||
| Q4 24 | $756.4M | $392.3M | ||
| Q3 24 | $707.6M | $363.6M | ||
| Q2 24 | $753.6M | $381.8M | ||
| Q1 24 | $631.7M | $258.7M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.2M | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 22.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.2M | $-25.4M | ||
| Q3 25 | $9.5M | $-26.6M | ||
| Q2 25 | $50.1M | $-23.3M | ||
| Q1 25 | $2.4M | $-40.4M | ||
| Q4 24 | $50.1M | $-18.8M | ||
| Q3 24 | $-593.0K | $-25.2M | ||
| Q2 24 | $16.1M | $-29.1M | ||
| Q1 24 | $54.8M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $335.0K | — | ||
| Q4 24 | $-98.5M | — | ||
| Q3 24 | $-2.8M | — | ||
| Q2 24 | $-126.7M | — | ||
| Q1 24 | $54.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | -201.8% | — | ||
| Q3 24 | -12.1% | — | ||
| Q2 24 | -490.5% | — | ||
| Q1 24 | 224.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 304.4% | — | ||
| Q3 24 | 9.6% | — | ||
| Q2 24 | 553.0% | — | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 22.01× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACTG
| Energy Operations | $16.0M | 32% |
| Transportation Safety | $10.4M | 21% |
| Office Storage And Display Solutions | $8.4M | 17% |
| Printers Consumables And Parts | $6.5M | 13% |
| Natural Gas Reserves | $5.1M | 10% |
| Natural Gas Liquids Reserves | $3.3M | 7% |
RYTM
Segment breakdown not available.
